Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)

NCT06109779 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

757

Enrollment

INDUSTRY

Sponsor class

Conditions

Biliary Tract Cancer

Interventions

DRUG: Rilvegostomig
DRUG: Placebo
DRUG: Capecitabine
DRUG: Gemcitabine/Cisplatin
DRUG: S-1 [Tegafur/Oteracil/gimeracil]

Sponsor

AstraZeneca